Enhanced growth of murine melanoma in ultraviolet-irradiated skin is associated with local inhibition of immune effector mechanisms

Journal of Immunology

Volumn 157, Issue 2, 1996, Pages 781-786

  Donawho, Cherrie K ^a   Muller, H Konrad ^b   Bucana, Corazon D ^a   Kripke, Margaret L ^a,c  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TASMANIA   (Australia)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; IMMUNE RESPONSE; LYMPHOID CELL; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; T LYMPHOCYTE SUBPOPULATION; TUMOR REJECTION; ULTRAVIOLET IRRADIATION;

ANIMALS; CELL DIVISION; CELL MOVEMENT; FEMALE; GRAFT REJECTION; HYPERSENSITIVITY, DELAYED; IMMUNITY, CELLULAR; ISOANTIGENS; MELANOMA; MICE; MICE, INBRED C3H; NEOPLASMS, RADIATION-INDUCED; SKIN; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 0029903307     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Houghton, A. N., H. F. Oettgen, and L. J. Old. 1981. Malignant melanoma: current status of the search for melanoma-specific antigens. In Immunodermatology. B. Safai and R. A. Good, eds. Plenum Press, New York, p. 557.
2. Donawho, C., and M. L. Kripke. 1990. Immunogenicity and crossreactivity of syngeneic murine melanomas. Cancer Commun. 2:101.
3. Morton, D. L., L. J. Foshag, J. A. Nizze, R. K. Gupta, E. Famatiga, D. S. B. Hoon, and R. F Irie. 1989. Active specific immunotherapy in malignant melanoma. Semin. Surg. Oncol. 5:420.
4. Bystryn, J.-C. 1992. Immunogenicity and clinical activity of a polyvalent melanoma antigen vaccine prepared from shed antigens. Ann. NY Acad. Sci. 690:190.
5. Cochran, A. J. 1982. Tumor-directed cellular immunity in malignant melanoma and the antigens that evoke it. In Melanoma Antigens and Antibodies. R. A. Reisfeld and S. Ferrone, eds. Plenum Press, New York, p. 75.
6. Barnhill, R. L., and M. C. Mihm, Jr. 1992. Histopathology of malignant melanoma and its precursor lesions. In Cutaneous Melanoma, 2nd Ed. C. M. Balch, A. N. Houghton, G. W. Milton, A. J. Sober, and S.-J. Soong, eds. J. B. Lippincott, Philadelphia, p. 256.
7. Romerdahl, C. A., L. C. Stephens, C. Bucana, and M. L. Kripke. 1989. The role of ultraviolet radiation in the induction of melanocytic skin tumors in inbred mice. Cancer Commun. 1:209.
8. Romerdahl, C. A., C. Donawho, I. J. Fidler, and M. L. Kripke. 1988. Effect of ultraviolet-B radiation on the in vivo growth of murine melanoma cells. Cancer Res. 48:4007.
9. Donawho, C., and M. L. Kripke. 1991. Evidence that the local effect of UV radiation on the growth of murine melanomas is immunologically mediated. Cancer Res. 51:4176.
10. Howie, S., M. Norval, and J. Maingay. 1986. Exposure to low dose UVB radiation suppresses delayed-type hypersensitivity to herpes simplex virus in mice. J. Invest. Dermatol. 86:125.
11. Toews, G. B., P. R. Bergstresser, and J. W. Streilein. 1980. Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J. Immunol. 124:445.
12. Donawho, C. K., and M. L. Kripke. 1992. Lack of correlation between UV-induced enhancement of melanoma development and local suppression of contact hypersensitivity. Exp. Dermatol. 1:20.
13. Kripke, M. L. 1979. Speculations on the role of ultraviolet radiation in the development of malignant melanoma. J. Natl. Cancer Inst. 63:541.
14. MaGee, M. J., M. L. Kripke, and S. E. Ullrich. 1989. Suppression of the elicitation of the immune response to alloantigen by ultraviolet radiation. Transplantation 47:1008.
15. Okamoto, H., and M. L. Kripke. 1987. Effector and suppressor circuits of the immune response are activated in vivo by different mechanisms. Proc. Natl. Acad. Sci. USA 84:3841.
16. DH in HSV-1 infection. Immunology 60:419.
17. Chung, H.-T., D. K. Burnham, B. Robertson, L. K. Roberts, and R. A. Daynes. 1986. Involvement of prostaglandins in the immune alterations caused by the exposure of mice to ultraviolet radiation. J. Immunol. 137:2478.
18. Vermeer, M., and J. W. Streilein. 1990. Ultraviolet B light-induced alterations in epidermal Langerhans cells are mediated in part by tumor necrosis factor-alpha. Photodermatol. Photoimmunol. Photomed. 7:258.
19. Kripke, M. L. 1990. Effects of UV radiation on tumor immunity. J. Natl. Cancer Inst. 82:1392.
20. Denkins, Y., I. J. Fidler, and M. L. Kripke. 1989. Exposure of mice to UV-B radiation suppresses delayed hypersensitivity to Candida albicans. Photochem. Photobiol. 49:615.
21. + dendritic epidermal cells in murine epidermis during the evolution of ultraviolet radiation-induced skin cancers. Cancer Res. 49:4591.
22. Donawho, C., and M. L. Kripke. 1995. Photoimmunology of cutaneous melanoma. In: Photoimmunology. J. Krutmann, and C. Elmets, eds. Blackwell Science, Inc., Cambridge, p. 119.
23. Polla, L., R. Margolis, C. Goulston, J. A. Parrish, and R. D. Granstein. 1986. Enhancement of the elicitation phase of the murine contact hypersensitivity response by prior exposure to local ultraviolet radiation. J. Invest. Dermatol. 86:13.
24. Chen, P. W., and H. N. Ananthaswamy. 1993. Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2. J. Immunol. 151:244.
25. Armstrong, B. K. 1988. Epidemiology of malignant melanoma: intermittent or total accumulated exposure to the sun? J. Dermatol. Surg. Oncol. 14:835.
26. O'Dell, B. L., R. T. Jessen, L. E. Beeker, R. T. Jackson, and E. B. Smith. 1980. Diminished immune response in sun-damaged skin. Arch. Dermatol. 116:559.
27. Schwartz, S. M., B. K. Armstrong, and N. S. Weiss. 1987. Seasonal variation in the incidence of cutaneous malignant melanoma: an analysis by body site and histologic type. Am. J. Epidemiol. 126:102.
28. Braun, M. M., M. A. Tucker, S. S. Devesa, and R. N. Hoover. 1994. Seasonal variation in frequency of diagnosis of cutaneous malignant melanoma. Melanoma Res. 4:235.